ArticleMethods in molecular biology (Clifton, N.J.)2025
Targeted Absolute Quantification of Protein Biomarkers in Cerebrospinal Fluid by FastCAT.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Targeted quantification assays for DNA repair and handling proteins and interactions in Huntington's disease models.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Absolute (molar) quantification of proteins in cerebrospinal fluid (CSF) provides reference values and ranges of their physiological variation for perspective biomarkers across a broad spectrum of neurological disorders. FastCAT (for Fast-track QconCAT) method employs targeted mass spectrometry and multiple recombinant stable-isotope labeled chimeric proteins (CPs) as internal calibrants for the accurate and consistent determination of molar concentrations of dozens of CSF proteins. No purification or external quantification of CPs is required. We demonstrate that FastCAT, powered by parallel reaction monitoring (PRM) detection of multiple quantotypic peptides per target proteins, can quantify the molar concentration of neurological biomarkers from neat CSF over a dynamic range of more than 1000-fold, with high precision (coefficient of variation <20%) and low detection limits (<1 nmol/L) in a single LC-MS/MS analysis.
Indexed as
Identifiers
40167911What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.